GE HealthCare Technologies Inc. (NASDAQ:GEHC) Shares Purchased by Forsta AP Fonden

Forsta AP Fonden boosted its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 3.5% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 138,475 shares of the company's stock after acquiring an additional 4,700 shares during the period. Forsta AP Fonden's holdings in GE HealthCare Technologies were worth $10,826,000 at the end of the most recent reporting period.

Several other hedge funds also recently added to or reduced their stakes in the business. Mesirow Financial Investment Management Inc. lifted its stake in shares of GE HealthCare Technologies by 39.6% in the 3rd quarter. Mesirow Financial Investment Management Inc. now owns 4,084 shares of the company's stock valued at $383,000 after purchasing an additional 1,159 shares during the last quarter. Cathy Pareto & Associates Inc. purchased a new stake in shares of GE HealthCare Technologies in the 4th quarter valued at approximately $670,000. LMR Partners LLP acquired a new position in shares of GE HealthCare Technologies in the 3rd quarter worth approximately $7,387,000. Principal Financial Group Inc. boosted its position in shares of GE HealthCare Technologies by 1.9% during the 3rd quarter. Principal Financial Group Inc. now owns 1,009,910 shares of the company's stock worth $94,780,000 after purchasing an additional 19,010 shares during the period. Finally, B. Metzler seel. Sohn & Co. Holding AG purchased a new stake in GE HealthCare Technologies in the third quarter valued at approximately $1,396,000. 82.06% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity at GE HealthCare Technologies

In related news, CEO Roland Rott sold 3,577 shares of the business's stock in a transaction on Wednesday, November 6th. The shares were sold at an average price of $86.48, for a total value of $309,338.96. Following the completion of the sale, the chief executive officer now directly owns 24,298 shares of the company's stock, valued at $2,101,291.04. The trade was a 12.83 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. 0.27% of the stock is currently owned by corporate insiders.

GE HealthCare Technologies Stock Down 0.9 %

NASDAQ:GEHC traded down $0.76 during trading hours on Monday, hitting $87.54. The company's stock had a trading volume of 1,197,700 shares, compared to its average volume of 2,624,957. The stock has a market capitalization of $40.00 billion, a P/E ratio of 24.08, a price-to-earnings-growth ratio of 2.92 and a beta of 1.14. The company has a current ratio of 1.23, a quick ratio of 0.98 and a debt-to-equity ratio of 1.12. The stock has a fifty day moving average of $82.87 and a 200-day moving average of $85.04. GE HealthCare Technologies Inc. has a 52-week low of $72.61 and a 52-week high of $94.55.

GE HealthCare Technologies Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 14th will be paid a dividend of $0.035 per share. This is a boost from GE HealthCare Technologies's previous quarterly dividend of $0.03. The ex-dividend date of this dividend is Tuesday, January 14th. This represents a $0.14 annualized dividend and a yield of 0.16%. GE HealthCare Technologies's payout ratio is presently 3.85%.

Wall Street Analysts Forecast Growth

GEHC has been the subject of several research analyst reports. Jefferies Financial Group upgraded GE HealthCare Technologies from a "hold" rating to a "buy" rating and raised their price target for the stock from $95.00 to $103.00 in a research report on Wednesday, January 8th. Wells Fargo & Company raised their target price on GE HealthCare Technologies from $95.00 to $96.00 and gave the company an "overweight" rating in a report on Thursday, October 31st. One research analyst has rated the stock with a sell rating, four have given a hold rating, nine have assigned a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, GE HealthCare Technologies has an average rating of "Moderate Buy" and a consensus price target of $96.00.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.